miR-145, which is down-regulated in HCC patients, can suppress the expression of YTHDF2 by directly targeting the 3′UTR of YTHDF2 mRNA(Yang et al., 2017). The gene discussed is YTHDF2; the disease is hepatocellular carcinoma.